2026 revenue consensus $345.73M.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSTL:
- Castle Biosciences Posts Strong Q1 Results, Raises 2026 Guidance
- Castle Biosciences price target lowered to $40 from $50 at Canaccord
- Castle Biosciences to present new data from DecisionDx-Melanoma test at AAD
- Castle announces publication of DecisionDx-Melanoma’s i31-SLNB study results
- Castle Biosciences announces new data from study evaluating i31SLNB